Cargando…
Dapsone and doxycycline could be potential treatment modalities for COVID-19
Autores principales: | Farouk, Ahmed, Salman, Samar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175857/ https://www.ncbi.nlm.nih.gov/pubmed/32339778 http://dx.doi.org/10.1016/j.mehy.2020.109768 |
Ejemplares similares
-
Benefits of Using Dapsone in Patients Hospitalized with COVID-19
por: Kanwar, Badar A., et al.
Publicado: (2022) -
Dapsone in dermatology and beyond
por: Wozel, Gottfried, et al.
Publicado: (2013) -
Doxycycline as a potential partner of COVID-19 therapies
por: Malek, Alexandre E., et al.
Publicado: (2020) -
Dapsone-Induced Hypoxia
por: Keerty, Dinesh, et al.
Publicado: (2020) -
Dapsone hypersensitivity syndrome
por: Zhao, Qing, et al.
Publicado: (2023)